Abstract
The combination of biologic response modifiers, particularly IFN-α and/or IL-2, with traditional chemotherapeutic drugs, is often referred to as 'biochemotherapy' or 'chemoimmunotherapy'.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 480-485 |
| Number of pages | 6 |
| Journal | Drug News and Perspectives |
| Volume | 8 |
| Issue number | 8 |
| State | Published - 1995 |
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery